The transgenic construct is designed to contain a rat Ggt1 promoter directing expression of a human diphtheria toxin receptor (DTR; heparin-binding epidermal growth factor-like growth factor (HBEGF)) fused to a hemagglutinin (HA) tag and a polyadenylation (polyA) sequence. (J:193980)